Does DACARBAZINE Cause Hyperammonaemic encephalopathy? 7 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Hyperammonaemic encephalopathy have been filed in association with DACARBAZINE (Dacarbazine). This represents 0.1% of all adverse event reports for DACARBAZINE.
7
Reports of Hyperammonaemic encephalopathy with DACARBAZINE
0.1%
of all DACARBAZINE reports
3
Deaths
4
Hospitalizations
How Dangerous Is Hyperammonaemic encephalopathy From DACARBAZINE?
Of the 7 reports, 3 (42.9%) resulted in death, 4 (57.1%) required hospitalization, and 3 (42.9%) were considered life-threatening.
Is Hyperammonaemic encephalopathy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DACARBAZINE. However, 7 reports have been filed with the FAERS database.
What Other Side Effects Does DACARBAZINE Cause?
Febrile neutropenia (501)
Off label use (471)
Neutropenia (400)
Drug ineffective (261)
Pyrexia (245)
Neuropathy peripheral (239)
Product use in unapproved indication (219)
Disease progression (204)
Nausea (203)
Anaemia (186)
What Other Drugs Cause Hyperammonaemic encephalopathy?
VALPROIC ACID (455)
FLUOROURACIL (156)
VALPROATE (120)
DIVALPROEX (119)
OXALIPLATIN (107)
TOPIRAMATE (101)
RISPERIDONE (96)
QUETIAPINE (91)
LEVETIRACETAM (71)
LEUCOVORIN (62)
Which DACARBAZINE Alternatives Have Lower Hyperammonaemic encephalopathy Risk?
DACARBAZINE vs DACLATASVIR
DACARBAZINE vs DACLIZUMAB
DACARBAZINE vs DACOMITINIB
DACARBAZINE vs DACTINOMYCIN
DACARBAZINE vs DALBAVANCIN